Trial Profile
Partially Blinded Study to Assess Reactogenicity and Safety of GSK Biologicals' Tritanrix-HepB/Hib-MenAC vs Tritanrix-HepB/Hiberix in Healthy Infants After a Hepatitis B Birth Dose.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 13 Jul 2023
Price :
$35
*
At a glance
- Drugs Hib-DTP-hepatitis B-meningococcal vaccine groups A and C conjugate (Primary) ; Hib-DTP hepatitis B vaccine (Tritanrix-HepB/Hiberix)
- Indications Diphtheria; Haemophilus infections; Hepatitis B; Meningococcal group A infections; Meningococcal group C infections; Pertussis; Tetanus
- Focus Adverse reactions
- Sponsors GlaxoSmithKline; GSK
- 17 Feb 2006 New trial record